Nautilus Biotechnology to Participate in B. Riley Securities’ Disruptive Biotech Enabling Technologies – Proteomics, Virtual Conference

Rhea-AI Summary

Nautilus Biotechnology, a leader in single-molecule protein analysis, will participate in the B. Riley Securities’ Disruptive Biotech Enabling Technologies – Proteomics Virtual Conference on April 6, 2023. The management will feature in a fireside chat at 10:30 a.m. Pacific Time. Investors and interested individuals can tune in to a live and archived webcast on the company’s website. Nautilus aims to revolutionize proteomics by enhancing access to the proteome, fostering significant advancements in human health. To learn more, visit www.nautilus.bio.

SEATTLE, March 23, 2023 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform, today announced the company will be participating in the upcoming B. Riley Securities’ Disruptive Biotech Enabling Technologies – Proteomics, Virtual Conference.

Nautilus’ management is scheduled to participate in a fireside chat on Thursday, April 6^th at 10:30 a.m. Pacific Time / 1:30 p.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation on the company’s website on the “Investors” section of the company website at: www.nautilus.bio.

About Nautilus Biotechnology, Inc.
With its corporate headquarters in Seattle and its research and development headquarters in the San Francisco Bay Area, Nautilus is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the proteome. Nautilus’ mission is to transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. To learn more about Nautilus, visit www.nautilus.bio.

Media Contact
press@nautilus.bio

Investor Contact
investorrelations@nautilus.bio

FAQ

What event is Nautilus Biotechnology participating in?

Nautilus Biotechnology is participating in the B. Riley Securities’ Disruptive Biotech Enabling Technologies – Proteomics Virtual Conference.

When will Nautilus present at the B. Riley conference?

Nautilus will present on April 6, 2023, at 10:30 a.m. Pacific Time.

How can I access Nautilus' presentation?

You can access the live and archived webcast of Nautilus' presentation on their website under the 'Investors' section.

What is Nautilus Biotechnology's mission?

Nautilus aims to transform proteomics by democratizing access to the proteome and advancing human health.

What is the ticker symbol for Nautilus Biotechnology?

The ticker symbol for Nautilus Biotechnology is NAUT.